Endo Flashcards
Chronic Adrenal Insufficiency primary vs secondary defintion
*adrenal gland does not produce enough hormones
Hypothalamus (CRH) 🡪 pituitary (ACTH) 🡪 adrenal (cortisol)
RAAS 🡪 aldosterone
Primary (Addison Disease): adrenal gland destruction
*lack of cortisol & aldosterone
Etiologies:
*autoimmune MCC in the US
*infection (TB, HIV) MCC in developing countries
*vascular: thrombosis or hemorrhage 🡪 Waterhouse-Friderichsen
*others: trauma, metastatic disease, meds (ketoconazole)
Secondary: pituitary failure of ACTH secretion
*lack of cortisol ONLY; aldosterone intact due to RAAS
Etiologies:
*hx of exogenous glucocorticoid use MCC overall
*hypopituitarism
Chronic Adrenal Insufficiency sx
Sxs due to lack of cortisol:
*weakness, myalgias, fatigue
*GI: weight loss, anorexia, N/V/D, abdominal pain
*HA, sweating, abnormal menstruation
*mild hyponatremia, salt craving
*hypotension, hypoglycemia
Addison: sxs due to lack of sex hormones & aldosterone
*hyperpigmentation (↑ ACTH stimulates melanocyte-stimulating hormone secretion)
*orthostatic hypotension
*women: loss of libido, amenorrhea, loss of axillary/pubic hair
Chronic Adrenal Insufficiency dx and tx
Baseline labs: 8am ACTH, cortisol, renin
*↑ renin (esp. w/ primary)
*cortisol <3µg/dL = (+) adrenal insufficiency
*Primary: ↑ ACTH
*Secondary: ↓ ACTH
Labs:
*hypoglycemia
Addison:
*hyponatremia, hyperkalemia
*non-anion gap metabolic acidosis
Screening: high-dose ACTH (Cosyntropin)
*no rise in cortisol 🡪 Addison (primary)
*destroyed adrenal gland = no response
*normal rise in cortisol 🡪 secondary
*adrenal gland in intact = responds
tx
Glucocorticoid replacement:
*hydrocortisone first line
*dexamethasone
Addison 🡪 (+) mineralocorticoid
*fludrocortisone
Illness, surgery, high fever, stress:
*3x the normal PO dose
Adrenal (Addisonian) Crisis definition, sx, dx, tx
*sudden worsening of sxs
*precipitated by a “stressful” event (illness, surgery, trauma, volume loss, hypothermia, MI, fever, sepsis, hypoglycemia, steroid withdrawal, etc.)
Etiologies:
*abrupt withdrawal of steroids (w/o tapering) MCC
*previously undiagnosed + subject to stress
*diagnosed + no increase in meds during stress
*bilateral adrenal infarction (hemorrhage)
sx
Shock:
*hypotension
*hypovolemia
Profound weakness, severe abdominal pain, peripheral vascular collapse, electrolyte abnormalities, shock
dx
Labs:
*hyponatremia
*hyperkalemia
*hypoglycemia
*cortisol, aldosterone, ACTH, renin, CBC
tx
*isotonic fluids (NS or D5NS) plus
*IV hydrocortisone
*dexamethasone if undiagnosed
*reversal of electrolyte disorders
*fludrocortisone
Diabetes Insipidus central vs nephrogenic definition
*inability of the kidney to concentrate urine, leading to production of large amounts of dilute urine
2 TYPES:
Central: no production of ADH (MC)
*idiopathic MCC, destruction of posterior pituitary, head trauma, CNS tumor, infection
Nephrogenic: partial or complete renal insensitivity to ADH
*lithium, amphotericin B, hypokalemia, hypercalcemia, acute tubular necrosis, hyperparathyroidism
Diabetes Insipidus sx, dx, tx
sx
*polyuria + polydipsia
*high-volume nocturia
Neurologic sxs of hypernatremia
*confusion, lethargy, disorientation
*seizures, coma
PE:
*dehydration, hypotension, rapid vascular collapse
dx
*increased serum osmolarity
*decreased urine osmolality & specific gravity
*increased urine volume
Fluid deprivation test: *establishes dx
*continued production of large amounts of dilute urine (low urine osmolality)
ADH stimulation test: *distinguishes central v. nephro
*central: responds to ADH
*nephrogenic: continued production of large amounts of dilute urine (no response to ADH)
tx
Central:
*desmopressin (DDAVP) first line
*carbamazepine second line
Nephrogenic:
*correct underlying cause
*hydrochlorothiazide, indomethacin, or amiloride is sxs persist
*sodium & protein restriction
DM Type 1 defintion
90% autoimmune – pancreatic β cells fail to respond to stimuli & undergo autoimmune destruction
Onset: usually <30 (3/4 diagnosed in childhood)
*peaks at 4-6y then again at 10-14y
*NOT associated w/ obesity
Type 1A: autoimmune (MC); HLA-DR3 & HLA-DR4 association
Type 1B: non-autoimmune β cell destruction
Main RF: family hx (first-degree relative)
Diabetic Ketoacidosis (DKA):
*infection MCC – others: D/C or inadequate insulin therapy, undiagnosed DM, MI, CVA, pancreatitis
DM Type 1 sx
3 initial presentations:
*Classic new onset: polydipsia, polyuria, & weight loss + hyperglycemia & ketonemia (or kentonuria)
*DKA
*Silent (asymptomatic) incidental discovery
*perineal candidiasis – common in young children/girls
*acute visual disturbances
DKA: sxs evolve rapidly over 24h
Child appears acutely ill & suffers from moderate to profound dehydration
*polyuria, polydipsia
*fatigue, HA, AMS
*N/V, abdominal pain
PE: tachycardia, tachypnea, hypotension, ↓ skin turgor
*fruity (acetone) breath
*Kussmaul respirations (deep, labored breathing)
DM1 Associations & Solutions:
Dawn Phenomenon: normal glucose until 2-8am when it rises; results from ↓ insulin sensitivity & a nightly surge of counter-regulatory hormones during nighttime fasting
TX: bedtime injection of NPH to blunt morning hyperglycemia; avoid carbs late at night
Somogyi Effect: nocturnal hypoglycemia followed by rebound hyperglycemia d/t surge in growth hormone
TX: ↓ nighttime NPH dose or give bedtime snack
Insulin Waning: a progressive rise in glucose from bed to morning
TX: change of insulin dose to bedtime
DM Type 1 dx
Criteria: one of the following
1) Fasting plasma glucose ≥126mg/dL on >1 occasion
2) Random plasma glucose ≥200mg/dL + classic s/sxs of hyperglycemia
3) OGTT – plasma glucose ≥200mg/dL after 2hr
4) HbA1C ≥6.5% confirmed by repeat testing
Autoantibodies: GAD65, IA2, insulin
*any (+) autoantibodies 🡪 assume DM1
LOW insulin & C-peptide
*urine: glucose, ketones
DKA:
*BG >250mg/dL (usually <800mg/dL)
*acidic pH <7.3, anion gap usually >20mEq/L
*bicarb <15-18
*(+) urine/serum ketones
Potassium: total body K is depleted, but serum K is normal/elevated (K shift from intracellular fluid to extracellular fluid)
DM Type 1 tx
INSULIN THERAPY!!
*Multiple Daily Injections (MDI): long-acting insulin injections 1-2x/d + rapid or short-acting insulin before each meal/snack
*Insulin Pump: delivers continuous SC infusion of rapid or short-acting insulin + supplemented boluses before each meal/snack
DKA: SIPS – saline, insulin (regular), potassium repletion, search for underlying cause
Saline: isotonic 0.9% (normal saline) until hypotension & orthostasis resolves
*then switch to ½ NS (0.45%)
*once serum glucose reaches ~200-250, add dextrose (to prevent hypoglycemia from insulin)
Insulin: for pts w/ K ≥3.3mEq/L – regular insulin continuous infusion; 2 regimens
*0.1units/kg IV bolus then continuous IV infusion 0.1units/kg/h
*NO BOLUS, start continuous IV infusion 0.14units/kg/h
*if serum glucose doesn’t fall by at least 50-70mg/dL in the first hour, DOUBLE rate of insulin infusion
Potassium: regardless of serum K, pts have a large total body K deficit
*K <3.3mEq/L – HOLD INSULIN; give IV KCl 20-40mEq/L until K above 3.3mEq/L
*K 3.3-5.3mEq/L – give KCl 20-30mEq/L IV fluid
*maintain SERUM K 4-5mEq/L
*K >5.3mEq/L – DO NOT GIVE K; check serum K q2h & delay KCl admin until serum K <5.3mEq/L
Sodium Bicarbonate: ONLY GIVEN TO PTS W/ pH <6.90 (admin associated w/ complications of overcorrection & increased cerebral edema)
DM Type II defintion, sx, dx, tx
Combination of insulin insensitivity (resistance) & relative impairment of insulin secretion
Risk Factors: obesity greatest RF, decreased physical activity, family hx, metabolic syndrome
Hyperosmolar Hyperglycemic State (HHS): seen in older patients, associated w/ more severe dehydration; no ketosis or acidosis
sx
3 Ps: polyuria, polydipsia, polyphagia
*poor wound healing
*increased infections
HHS: s/sxs develop more insidiously
*polyuria, polydipsia, weight loss, profound dehydration
*NEURO SXS – mental obtundation, coma, seizures
*fatigue, weakness, N/V
PE: tachycardia, hypotension, ↓ skin turgor, ↑ capillary refill time
dx
Criteria: one of the following
1) Fasting plasma glucose ≥126mg/dL on >1 occasion
2) Random plasma glucose ≥200mg/dL + classic s/sxs of hyperglycemia
3) OGTT – plasma glucose ≥200mg/dL after 2hr
4) HbA1C ≥6.5% confirmed by repeat testing
HIGH insulin & C-peptide
HHS:
*BG >600mg/dL, often >1000mg/dL
*Plasma osmolality >320
*pH >7.3, bicarb >18
*ketones: small
tx
Initial: diet, exercise, lifestyle changes
Asymptomatic:
*metformin MC initial
*intolerance/CI: GLP-1 receptor agonists, SGLT2 inhibitors
Symptomatic: insulin indicated as initial therapy
HHS: fluids most important management!!
*start IV fluids – 0.9% NaCl at 1L/h
*once glucose ~300mg/dL 🡪 5% dextrose w/ 0.45% NaCl at 150-250mL/h
Insulin: 0.1units/kg bolus then 0.1units/kg/h continuous IV infusion
Potassium: same guidelines as in DM1
DMT1 medications: rapid acting and long acting
rapid acting
aspart
lispro
glulisine
long acting
detemir
glargine
degludec
DMT2 medications: Biguanides MOA, CI
metformin- first line
MOA: Decreased hepatic glucose production
CI: Severe renal or hepatic impairment
- held before giving iodinated contrast, resumed 48hrs after
DMT2 medications: Sulfonylureas MOA
2nd gen: glipizide, glyburide, glimepiride
1st gen: tolbutamide, chlorpropamide
MOA: Stimulates pancreatic beta cell insulin release
DMT2 medications: GLP-1 Agonists MOA, CI
Iiraglutide, semaglutide, dulaglutide
MOA: Increased glucose-dependent insulin secretion
CI: Hx of gastroparesis or pancreatitis
Medullary thyroid cancer